Institutional members access full text with Ovid®

Share this article on:

Screening for Fetal Aneuploidy: Is Maternal Age Relevant?

HAWK, ANGELA F. MD*; SALLER, DEVEREUX N. MS, MD

Clinical Obstetrics and Gynecology: March 2012 - Volume 55 - Issue 1 - p 217–225
doi: 10.1097/GRF.0b013e3182488309
Imaging in Obstetrics: State of the Art

The process of genetic screening has evolved from a simple notation of maternal age to a complex algorithm incorporating age, maternal serum screening, and sonographic findings. The extent to which each of these variables should contribute to the overall screening result is much debated and deserves continued research. It is clear that maternal age provides useful information when used as part of this equation but should not represent the sole screening modality. The use of genetic screening in a general population should be examined in terms of cost effectiveness without sacrificing patient preference and autonomy.

*Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Medical University of South Carolina, Charleston, South Carolina;

Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Virginia, Charlottesville, Virginia

The authors declare that they have nothing to disclose.

Correspondence: Angela F. Hawk, MD, MUSC, Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Medical University of South Carolina, Suite 634, MSC, 619, Charleston, SC. E-mail: hawkaf@musc.edu, angelafhawk@gmail.com

© 2012 Lippincott Williams & Wilkins, Inc.